🇺🇸 FDA
Patent

US 11542486

Human kynureninase enzyme variants having improved pharmacological properties

granted A61KA61K35/17A61K38/46

Quick answer

US patent 11542486 (Human kynureninase enzyme variants having improved pharmacological properties) held by The Board of Regents of the University of Texas System expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K35/17, A61K38/46, A61K39/3955, A61K47/60